Inactive Instrument

Press Releases StemCells Inc Nasdaq

Equities

US85857R2040

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jul. 08	Microbot Medical Enrolls First Patient in Human Clinical Trial of Liberty Surgical System	MT
Jul. 08	Microbot Medical Enrolled the First Patient in Its Pivotal Human Clinical Trial	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial	Jul. 09	GL
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial	Jul. 08	GL
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial	Jul. 03	GL
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial	Jun. 20	GL
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial	Jun. 17	GL
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial	Jun. 17	AQ
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	Jun. 04	GL
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	Jun. 03	GL
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial	Jun. 03	GL
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™	Apr. 29	GL
Microbot Medical Shares Status Following Recent Geopolitical Events	Apr. 15	GL
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	Feb. 05	GL
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters	Jan. 30	GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	Jan. 18	GL
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	Jan. 18	AQ
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules	Dec. 29	GL
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	Dec. 28	GL
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	Dec. 28	AQ
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic	Dec. 14	GL
Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study	Dec. 07	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases StemCells Inc Nasdaq

Equities

US85857R2040

Press Releases

Filters